Posted on July 17, 2013
Women who received a vaccine targeting two types of the human papilloma virus (HPV) that cause 70 percent of cervical cancers had the added benefit of protection against oral HPV infection, which can lead to cancer of the tonsils and throat (oropharyngeal cancer). The results were published July 17, 2013, in PLOS ONE.
NCI News Note: HPV vaccine shown to also protect against oral HPV infection
The National Cancer Institute (NCI) news note for the study